Variant report

Variant	nsv876018
Chromosome Location	chr2:234653938-234666461
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234665213-234665815	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:234653876-234654428	HepG2	liver:	n/a	n/a
3	ATF3	chr2:234653988-234654486	A549	lung:	n/a	n/a
4	ATF3	chr2:234665232-234665880	A549	lung:	n/a	n/a
5	ATF3	chr2:234665180-234665897	A549	lung:	n/a	n/a
6	BCL3	chr2:234653885-234654544	A549	lung:	n/a	n/a
7	BCL3	chr2:234665162-234665915	A549	lung:	n/a	n/a
8	BCL3	chr2:234653958-234654499	A549	lung:	n/a	n/a
9	BCL3	chr2:234665053-234665927	A549	lung:	n/a	n/a
10	BHLHE40	chr2:234665426-234665807	HepG2	liver:	n/a	n/a
11	BHLHE40	chr2:234665457-234665720	HepG2	liver:	n/a	n/a
12	BHLHE40	chr2:234654058-234654451	HepG2	liver:	n/a	n/a
13	CBX3	chr2:234659353-234659614	K562	blood:	n/a	n/a
14	CEBPB	chr2:234653961-234654410	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
15	CEBPB	chr2:234656934-234657289	HepG2	liver:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
16	CEBPB	chr2:234665312-234665783	A549	lung:	n/a	chr2:234665476-234665488 chr2:234665429-234665440
17	CEBPB	chr2:234665270-234665777	HepG2	liver:	n/a	chr2:234665476-234665488 chr2:234665429-234665440
18	CEBPB	chr2:234653902-234654598	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
19	CEBPB	chr2:234665395-234665774	HepG2	liver:	n/a	chr2:234665476-234665488 chr2:234665429-234665440
20	CEBPB	chr2:234656935-234657273	A549	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
21	CEBPB	chr2:234657008-234657264	IMR90	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
22	CEBPB	chr2:234653943-234654318	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
23	CEBPB	chr2:234653892-234654497	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
24	CEBPB	chr2:234653979-234654335	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
25	CEBPB	chr2:234665245-234665826	HepG2	liver:	n/a	chr2:234665476-234665488 chr2:234665429-234665440
26	CEBPB	chr2:234665229-234665946	A549	lung:	n/a	chr2:234665476-234665488 chr2:234665429-234665440
27	CEBPB	chr2:234665343-234665750	HepG2	liver:	n/a	chr2:234665476-234665488 chr2:234665429-234665440
28	CEBPB	chr2:234665269-234665761	A549	lung:	n/a	chr2:234665476-234665488 chr2:234665429-234665440
29	CEBPB	chr2:234654020-234654389	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
30	CEBPB	chr2:234653908-234654385	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
31	CEBPD	chr2:234654049-234654478	HepG2	liver:	n/a	n/a
32	CEBPD	chr2:234665334-234665685	HepG2	liver:	n/a	n/a
33	CEBPD	chr2:234665351-234665763	HepG2	liver:	n/a	n/a
34	CHD2	chr2:234654164-234654273	HepG2	liver:	n/a	n/a
35	CREB1	chr2:234665410-234665788	A549	lung:	n/a	n/a
36	CREB1	chr2:234653968-234654547	HepG2	liver:	n/a	n/a
37	CREB1	chr2:234665450-234665902	A549	lung:	n/a	n/a
38	CREB1	chr2:234654194-234654509	A549	lung:	n/a	n/a
39	CREB1	chr2:234653888-234654608	HepG2	liver:	n/a	n/a
40	CREB1	chr2:234654062-234654459	A549	lung:	n/a	n/a
41	CTCF	chr2:234665140-234665221	GM10248	blood:	n/a	n/a
42	ELF1	chr2:234665363-234665770	HepG2	liver:	n/a	n/a
43	ELF1	chr2:234665287-234665705	A549	lung:	n/a	n/a
44	EP300	chr2:234665194-234665902	HepG2	liver:	n/a	chr2:234665216-234665225
45	EP300	chr2:234653933-234654548	HepG2	liver:	n/a	chr2:234654068-234654082
46	EP300	chr2:234653700-234654700	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
47	EP300	chr2:234665041-234665982	A549	lung:	n/a	chr2:234665216-234665225
48	EP300	chr2:234654030-234654453	HepG2	liver:	n/a	chr2:234654068-234654082
49	EP300	chr2:234664946-234666071	A549	lung:	n/a	chr2:234665216-234665225
50	EP300	chr2:234665382-234665803	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234663937-234663987	RPTEC	kidney:	n/a
2	chr2:234663937-234663987	RPTEC	kidney:	n/a
3	chr2:234655709-234655759	RPTEC	kidney:	n/a
4	chr2:234655709-234655759	SKMC	muscle:	n/a
5	chr2:234663900-234663950	HNPCEpiC	eye:	n/a
6	chr2:234661536-234661586	PANC-1	pancreas:	n/a
7	chr2:234662759-234662809	HAEpiC	amniotic membrane:	n/a
8	chr2:234663937-234663987	PFSK-1	brain:	n/a
9	chr2:234662759-234662809	BE2_C	brain:	n/a
10	chr2:234662759-234662809	HRCEpiC	kidney:	n/a
11	chr2:234662401-234662451	Jurkat	blood:	n/a
12	chr2:234663900-234663950	GM19239	blood:	n/a
13	chr2:234662401-234662451	A549	lung:	n/a
14	chr2:234663729-234663779	BE2_C	brain:	n/a
15	chr2:234663729-234663779	U87	brain:	n/a
16	chr2:234653891-234653941	H1-hESC	embryonic stem cell:	embryo
17	chr2:234663937-234663987	HCPEpiC	choroid plexus:	n/a
18	chr2:234662759-234662809	ProgFib	skin:	n/a
19	chr2:234662401-234662451	HCT-116	colon:	n/a
20	chr2:234663900-234663950	Jurkat	blood:	n/a
21	chr2:234663937-234663987	K562	blood:	n/a
22	chr2:234661536-234661586	HRCEpiC	kidney:	n/a
23	chr2:234655709-234655759	BE2_C	brain:	n/a
24	chr2:234664336-234664386	AG10803	skin:	n/a
25	chr2:234662401-234662451	GM19239	blood:	n/a
26	chr2:234663729-234663779	AoSMC	blood vessel:	n/a
27	chr2:234653891-234653941	ovcar-3	ovarian:	n/a
28	chr2:234653891-234653941	HepG2	liver:	n/a
29	chr2:234663729-234663779	AG04450	lung:	fetal
30	chr2:234663937-234663987	HPAEpiC	pulmonary alveolar:	n/a
31	chr2:234653891-234653941	A549	lung:	n/a
32	chr2:234662401-234662451	HUVEC	blood vessel:	n/a
33	chr2:234663937-234663987	Jurkat	blood:	n/a
34	chr2:234655709-234655759	NH-A	brain:	n/a
35	chr2:234661536-234661586	AG09319	gingival:	n/a
36	chr2:234662401-234662451	SAEC	small airway:	n/a
37	chr2:234664336-234664386	CMK	blood:	n/a
38	chr2:234662759-234662809	NHBE	bronchial:	n/a
39	chr2:234663900-234663950	HepG2	liver:	n/a
40	chr2:234661536-234661586	AG04450	lung:	fetal
41	chr2:234663937-234663987	MCF-7	breast:	n/a
42	chr2:234664336-234664386	H1-hESC	embryonic stem cell:	embryo
43	chr2:234663937-234663987	IMR90	lung:	fetal
44	chr2:234655709-234655759	GM12892	blood:	n/a
45	chr2:234662759-234662809	AG04449	skin:	fetal
46	chr2:234664336-234664386	GM12892	blood:	n/a
47	chr2:234655709-234655759	GM12878	blood:	n/a
48	chr2:234662759-234662809	NH-A	brain:	n/a
49	chr2:234664336-234664386	GM06990	blood:	n/a
50	chr2:234663900-234663950	SK-N-SH	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:234651385..234654197-chr2:234659573..234662296,2	MCF-7	breast:
2	chr2:234650134..234652973-chr2:234653062..234655371,2	MCF-7	breast:
3	chr17:63274126..63274957-chr2:234657055..234657979,2	MCF-7	breast:
4	chr2:234660399..234662742-chr2:234667989..234670944,2	MCF-7	breast:
5	2:234543708-234558325..2:234649753-234657866	Hela-S3	cervix:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT1A1-1	chr2:234659263-234659366	NONHSAT077510
2	lnc-HJURP-4	chr2:234663790-234663991	NR_037696
3	lnc-UGT1A1-1	chr2:234660991-234661189	NONHSAT077510
4	lnc-UGT1A1-1	chr2:234661849-234662302	NONHSAT077510
5	lnc-HJURP-4	chr2:234662962-234663437	NR_037696

Variant related genes	Relation type
UGT1A2P	TF binding region
ENSG00000248705	TF binding region
ENSG00000178836	TF binding region
UGT1A1	TF binding region
UGT1A8	TF binding region
DNAJB3	TF binding region
UGT1A2P	CpG island
ENSG00000248705	CpG island
ENSG00000178836	CpG island
UGT1A1	CpG island
UGT1A8	CpG island
DNAJB3	CpG island
ENSG00000242515	chromatin interactions
ENSG00000242366	chromatin interactions
ENSG00000241635	chromatin interactions
ENSG00000234143	chromatin interactions
ENSG00000227802	chromatin interactions

Extended variants
information (count: 576 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:576 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13426130	chr2:234653938-234653939	Weak transcription Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs191130828	chr2:234653965-234653966	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs565612187	chr2:234653984-234653985	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs531226985	chr2:234654026-234654027	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs190513469	chr2:234654112-234654113	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs376846605	chr2:234654133-234654134	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs567771888	chr2:234654165-234654166	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs530279744	chr2:234654169-234654170	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs548824716	chr2:234654197-234654198	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs565744032	chr2:234654236-234654237	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs530940349	chr2:234654284-234654285	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
12	rs182919627	chr2:234654285-234654286	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
13	rs28900379	chr2:234654322-234654323	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs571256965	chr2:234654354-234654355	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
15	rs536953064	chr2:234654367-234654368	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
16	rs556800643	chr2:234654382-234654383	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
17	rs11695484	chr2:234654449-234654450	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs148112408	chr2:234654457-234654458	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
19	rs553219755	chr2:234654513-234654514	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs573273105	chr2:234654538-234654539	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
21	rs377389606	chr2:234654583-234654584	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs543022659	chr2:234654610-234654611	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs188125843	chr2:234654705-234654706	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs555344502	chr2:234654730-234654731	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
25	rs530884234	chr2:234654744-234654745	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
26	rs544937305	chr2:234654764-234654765	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
27	rs191765409	chr2:234654775-234654776	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs530256545	chr2:234654811-234654812	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs547152411	chr2:234654851-234654852	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs371025099	chr2:234654857-234654858	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs565676121	chr2:234654881-234654882	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs184175169	chr2:234654900-234654901	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs187514797	chr2:234654911-234654912	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs573360161	chr2:234654912-234654913	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs35656900	chr2:234654926-234654927	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs540725782	chr2:234654998-234654999	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs546503927	chr2:234655067-234655068	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs141272199	chr2:234655076-234655077	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs538596800	chr2:234655117-234655118	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs371846977	chr2:234655139-234655140	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs536618082	chr2:234655141-234655142	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs4663968	chr2:234655144-234655145	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs575149330	chr2:234655184-234655185	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs567530423	chr2:234655200-234655201	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs537470722	chr2:234655216-234655217	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs553124614	chr2:234655286-234655287	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs375179260	chr2:234655293-234655294	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs4663333	chr2:234655303-234655304	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs4663969	chr2:234655313-234655314	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs192486679	chr2:234655333-234655334	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:83 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234620400-234659200	Weak transcription	Colonic Mucosa	Colon
2	chr2:234626600-234668400	Weak transcription	NHEK	skin
3	chr2:234646400-234666600	Weak transcription	Stomach Mucosa	stomach
4	chr2:234647800-234655000	Weak transcription	Gastric	stomach
5	chr2:234649800-234658800	Weak transcription	Rectal Mucosa Donor 29	rectum
6	chr2:234652600-234654400	Enhancers	Liver	Liver
7	chr2:234652600-234654600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr2:234652800-234658200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr2:234652800-234659200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr2:234653200-234654400	Enhancers	HepG2	liver
11	chr2:234653200-234655600	Enhancers	Fetal Intestine Small	intestine
12	chr2:234653800-234654200	Active TSS	A549	lung
13	chr2:234654200-234654800	Enhancers	Small Intestine	intestine
14	chr2:234654200-234655000	Enhancers	A549	lung
15	chr2:234654200-234655400	Enhancers	Duodenum Mucosa	Duodenum
16	chr2:234654200-234655400	Enhancers	Fetal Intestine Large	intestine
17	chr2:234654400-234654600	Flanking Active TSS	HepG2	liver
18	chr2:234654400-234656000	Flanking Active TSS	Liver	Liver
19	chr2:234654600-234655800	Bivalent Enhancer	HepG2	liver
20	chr2:234655000-234655200	Flanking Active TSS	A549	lung
21	chr2:234655000-234655600	Enhancers	Gastric	stomach
22	chr2:234655200-234655400	Enhancers	A549	lung
23	chr2:234655400-234655600	Flanking Active TSS	A549	lung
24	chr2:234655400-234656200	Enhancers	Pancreas	Pancrea
25	chr2:234655600-234656200	Enhancers	A549	lung
26	chr2:234656000-234656600	Enhancers	Liver	Liver
27	chr2:234656200-234659000	Weak transcription	A549	lung
28	chr2:234656600-234657000	Flanking Active TSS	Liver	Liver
29	chr2:234657000-234657200	Enhancers	Liver	Liver
30	chr2:234657200-234657600	Flanking Active TSS	Liver	Liver
31	chr2:234657600-234658000	Active TSS	Liver	Liver
32	chr2:234658000-234658200	Flanking Active TSS	Liver	Liver
33	chr2:234658200-234660600	Enhancers	Liver	Liver
34	chr2:234658200-234664000	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr2:234659200-234659800	ZNF genes & repeats	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr2:234659600-234660200	ZNF genes & repeats	Colonic Mucosa	Colon
37	chr2:234659600-234660800	ZNF genes & repeats	Fetal Intestine Small	intestine
38	chr2:234659800-234661800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
39	chr2:234660000-234666200	Weak transcription	Rectal Mucosa Donor 29	rectum
40	chr2:234660200-234666400	Weak transcription	Colonic Mucosa	Colon
41	chr2:234660600-234663800	Weak transcription	Liver	Liver
42	chr2:234661400-234662000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr2:234661400-234662200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr2:234661800-234662200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
45	chr2:234661800-234664200	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr2:234663600-234664000	ZNF genes & repeats	A549	lung
47	chr2:234663800-234664000	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr2:234663800-234664000	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr2:234663800-234664000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
50	chr2:234663800-234664000	Genic enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links